ELIZABETH OTTER: Open Payments
NPI 1639108293 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,418 in 70 payments from 17 companies in 2025. Trend: 2023 $3,570 · 2024 $4,075 · 2025 $2,418
Food & beverage: $2,332Education: $85
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 7 | $560 |
| ABBVIE INC. | 13 | $402 |
| Janssen Biotech, Inc. | 6 | $240 |
| GENZYME CORPORATION | 6 | $219 |
| Amgen Inc. | 4 | $179 |
| Galderma Laboratories, L.P. | 4 | $147 |
| Novartis Pharmaceuticals Corporation | 7 | $125 |
| UCB, Inc. | 5 | $102 |
| Regeneron Healthcare Solutions, Inc. | 1 | $85 |
| Incyte Corporation | 3 | $79 |
Products named: ADBRY, TREMFYA, SKYRIZI, DUPIXENT, Otezla, NEMLUVIO, ANZUPGO, COSENTYX.
Industry payments across MI — which companies pay providers there.
